PROPHASE LABS INC. -
0.7445
25-十一月-24 16:45:01
15 分钟延时
股票
-0.0244
-3.17%
今日范围
0.7402 - 0.7900
ISIN
N/A
来源
NASDAQ
-
04 5月 2023 08:30:01 条件 Nasdaq GlobeNewswire
-
28 4月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Launch of Redesigned Corporate Website
25 4月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
18 4月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Record Financial Results for the year ended December 31, 2022
28 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
21 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces New $6 Million Stock Repurchase Program
15 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test
13 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
07 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
01 3月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Plans to Initiate Clinical Trial of Equivir (OTC)
22 2月 2023 08:00:02 条件 Nasdaq GlobeNewswire
-
16 2月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
15 2月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
06 2月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
05 1月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
19 12月 2022 08:30:00 条件 Nasdaq GlobeNewswire
-
30 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
10 11月 2022 08:00:04 条件 Nasdaq GlobeNewswire
-
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
08 11月 2022 08:00:01 条件 Nasdaq GlobeNewswire